CY1108630T1 - Εξεταση βιοισοδυναμιας δια συνθεσεις οι οποιες περιεχουν σιδηρο - Google Patents

Εξεταση βιοισοδυναμιας δια συνθεσεις οι οποιες περιεχουν σιδηρο

Info

Publication number
CY1108630T1
CY1108630T1 CY20081101418T CY081101418T CY1108630T1 CY 1108630 T1 CY1108630 T1 CY 1108630T1 CY 20081101418 T CY20081101418 T CY 20081101418T CY 081101418 T CY081101418 T CY 081101418T CY 1108630 T1 CY1108630 T1 CY 1108630T1
Authority
CY
Cyprus
Prior art keywords
iron
biosobility
examination
compositions containing
containing iron
Prior art date
Application number
CY20081101418T
Other languages
English (en)
Inventor
Mary Jane Helenek
Ralph A Lange
Richard P Lawrence
Original Assignee
Vifor (International) Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32684391&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108630(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vifor (International) Ag filed Critical Vifor (International) Ag
Publication of CY1108630T1 publication Critical patent/CY1108630T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Περιγράφεται μια ταχεία μέθοδος προσδιορισμού της βιοϊσοδυναμίας που βασίζεται εις την κινητική της αναγωγής του σιδήρου (ΙΙΙ) προς σίδηρο (ΙΙ) σε ένα δείγμα της σύνθεσης. Περιγράφονται επίσης μέθοδοι ελέγχου ποιότητος και συνδυασμένα κουτιά.
CY20081101418T 2002-08-26 2008-12-08 Εξεταση βιοισοδυναμιας δια συνθεσεις οι οποιες περιεχουν σιδηρο CY1108630T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/227,445 US6911342B2 (en) 2002-08-26 2002-08-26 Bioequivalence test for iron-containing formulations
PCT/US2002/026989 WO2004019032A1 (en) 2002-08-26 2002-08-26 Bioequivalence test for iron-containing formulations
EP02768694A EP1540338B1 (en) 2002-08-26 2002-08-26 Bioequivalence test for iron-containing formulations

Publications (1)

Publication Number Publication Date
CY1108630T1 true CY1108630T1 (el) 2014-04-09

Family

ID=32684391

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101418T CY1108630T1 (el) 2002-08-26 2008-12-08 Εξεταση βιοισοδυναμιας δια συνθεσεις οι οποιες περιεχουν σιδηρο

Country Status (17)

Country Link
US (1) US6911342B2 (el)
EP (1) EP1540338B1 (el)
JP (1) JP4408807B2 (el)
KR (1) KR100908447B1 (el)
CN (1) CN1685227B (el)
AT (1) ATE410677T1 (el)
AU (1) AU2002331712A1 (el)
BR (1) BR0215853A (el)
CA (1) CA2494199C (el)
CY (1) CY1108630T1 (el)
DE (1) DE60229303D1 (el)
DK (1) DK1540338T3 (el)
ES (1) ES2315401T3 (el)
IL (1) IL167085A (el)
MX (1) MXPA05002159A (el)
PT (1) PT1540338E (el)
WO (1) WO2004019032A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169359B2 (en) * 2002-08-26 2007-01-30 Luitpold Pharmaceuticals, Inc. Bioequivalence test for iron-containing formulations
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
EP1733058B8 (en) 2004-03-16 2012-10-24 Navinta LLC Iron sucrose complexes and method of manufacture thereof
WO2006061685A1 (en) * 2004-12-06 2006-06-15 Emcure Pharmaceuticals Limited A cost-effective process for preparation of manufacture of iron sucrose
JP4797900B2 (ja) * 2006-09-12 2011-10-19 三浦工業株式会社 鉄の定量方法
JP4797902B2 (ja) * 2006-09-13 2011-10-19 三浦工業株式会社 鉄の定量方法
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
CN101680867B (zh) * 2008-01-15 2013-06-05 寺下真人 生物等效性的评价方法
US8058076B2 (en) 2009-03-31 2011-11-15 Astron Research Limited In-vitro method for testing bioequivalence of iron-sucrose formulation
CN101710113B (zh) * 2009-12-09 2013-04-03 南京生命能科技开发有限公司 一种测定铁-碳水化合物络合物浊点和游离糖缓冲系数的方法
IT1405688B1 (it) 2010-06-09 2014-01-24 Biofer Spa Nuovi complessi a basso peso molecolare tra ferro ed acido maltobionico, uso di questi per la somministrazione intramuscolare o sottocutanea nella terapia di stati anemici, e nuove composizioni farmaceutiche adatte a questi usi.
DK3930686T3 (da) 2019-02-28 2023-09-11 Renibus Therapeutics Inc Hidtil ukendt jernsammensætning og fremgangsmåder til fremstilling og anvendelse heraf
CN110551019A (zh) * 2019-09-12 2019-12-10 天津医科大学 一种亚铁糖(ⅱ)复合物、制备方法及其应用
AU2022334583A1 (en) 2021-08-27 2024-03-07 Vifor (International) Ag Iron compositions and methods of making and using them
CN114652844B (zh) * 2022-04-13 2023-10-20 南京大学 一种基于仿生学设计的纳米组装材料的制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389706A (en) * 1972-05-03 1983-06-21 Westinghouse Electric Corp. Digital computer monitored and/or operated system or process which is structured for operation with an improved automatic programming process and system
US5624668A (en) * 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations
US6624668B1 (en) * 2000-11-08 2003-09-23 Xilinx, Inc. Digitally programmable phase-lock loop for high-speed data communications
US7169359B2 (en) * 2002-08-26 2007-01-30 Luitpold Pharmaceuticals, Inc. Bioequivalence test for iron-containing formulations

Also Published As

Publication number Publication date
IL167085A (en) 2010-06-16
EP1540338A1 (en) 2005-06-15
EP1540338B1 (en) 2008-10-08
JP4408807B2 (ja) 2010-02-03
PT1540338E (pt) 2008-12-04
DK1540338T3 (da) 2009-02-09
KR20050083658A (ko) 2005-08-26
JP2005536738A (ja) 2005-12-02
ES2315401T3 (es) 2009-04-01
BR0215853A (pt) 2005-06-21
CN1685227A (zh) 2005-10-19
US20040038416A1 (en) 2004-02-26
KR100908447B1 (ko) 2009-07-21
US6911342B2 (en) 2005-06-28
EP1540338A4 (en) 2006-06-07
CA2494199A1 (en) 2004-03-04
MXPA05002159A (es) 2005-12-05
CA2494199C (en) 2007-02-06
ATE410677T1 (de) 2008-10-15
DE60229303D1 (de) 2008-11-20
CN1685227B (zh) 2013-09-04
WO2004019032A1 (en) 2004-03-04
AU2002331712A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
CY1108630T1 (el) Εξεταση βιοισοδυναμιας δια συνθεσεις οι οποιες περιεχουν σιδηρο
EP1546162A4 (en) METHODS BASED ON LUMINESCENCE AND PROBES FOR MEASURING CYTOCHROME P450 ACTIVITY
BRPI0608376A8 (pt) composição de ligação, método de uso de uma composição de ligação, e, kit de detecção
ATE443775T1 (de) Hif-prolylhydroxylase-aktivitätstest
DK1436427T3 (da) Fremgangsmåde og sammensætning til at vurdere antistofbehandlingsrespons
DE60230243D1 (de) Röntgenfluoreszenz-analysator
ATE347611T1 (de) Automatischer apparat zum messen von wassertoxizität
TW200505896A (en) Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist
DE60232322D1 (de) Verfahren
WO2002066975A3 (en) Tissue-based water quality biosensors for detecting chemical warfare agents
AU2001263771A1 (en) An assay method and kit for testing biological material for exposure to stress using biomarkers
MXPA04004018A (es) Metodos de separacion por exclusion para toxicidad de compuestos de prueba.
AU2002251326A1 (en) Method to analyse the kit genotype of pigs
CA2586476A1 (en) Apparatus and method for chemical imaging of a biological sample
DK1195605T3 (da) Metoder og kompositioner til screening af sphingosin modulatorer
EP1445327A4 (en) SCREENING METHOD FOR A MEDICAMENT ACTIVE ON THE CELL WALL
WO2003106385A3 (en) METHOD FOR SCREENING FUNGITOXIC COMPOUNDS
FR2846009B1 (fr) Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
DE60315189D1 (de) Verfahren zum untersuchen von krebs aggressivität mit polymerisierte aktin bestimmung
AU2003256515A1 (en) Method for identifying salt-sensitive persons
AU2003211601A1 (en) Novel hemepeptide
UA11184U (uk) Спосіб гасіння власної флуоресценції білків
UA37538A (uk) Спосіб кількісного визначення формальдегіду
GB2415195A (en) Peptides of IRF-1
AU2002360991A1 (en) Compositions, methods and kits for detection and quantification of plant and animal source contaminants